Expert NetworkExpert InterviewNVS

Slingshot members are talking to an expert! The topic is:

Discussing the potential of oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G).

Executed on:Apr 17, 2025 2:30 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Columbia University
  • Academic nephrologist with expertise in glomerular diseases; Associate Professor of Medicine at Columbia University Medical Center.
  • Currently manages ~50 patients with Lupus Nephritis and ~50 patients with IgAN.
  • Clinical and research interests are focused on glomerular diseases; heavily involved in a variety of clinical and translational studies including the NIH-sponsored CureGN and NEPTUNE cohort studies. 

Interview Goal

Discussing the effiacy/safety of iptacopan and how it compares to existing treatment options now that it has been FDA approved.

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.